Synopsis of recent research by authors named "Peter Hur"
- Peter Hur's recent research focuses primarily on real-world effectiveness and safety of advanced therapies for inflammatory bowel diseases, particularly ulcerative colitis (UC) and rheumatoid arthritis, employing systematic reviews and observational studies to gather evidence.
- His studies, such as those evaluating biosimilars for rheumatoid arthritis and tofacitinib for ulcerative colitis, highlight treatment patterns, clinical outcomes, and health-related quality of life, providing insights into the real-world applications of these therapies.
- Additionally, Hur's work on the Inflammatory Bowel Disease Questionnaire (IBDQ-32) and the economic impacts of functional status in psoriatic arthritis emphasizes the importance of patient-reported outcomes and their relationship to treatment effectiveness and healthcare costs.